Evonile Pharma Sets Nov 11 Record Date for ₹9,000 Cr Rights Issue

Evonile Pharma Ltd has announced November 11, 2026, as the record date for its upcoming Rights Issue of partly paid-up equity shares. The company plans to raise up to ₹9,000 million (₹900 Crore) through this issue. The Rights Issue Committee has approved an issue price of ₹860 per share, with a total of 10,287,832 shares to be issued. The entitlement ratio is 5 Rights Shares for every 12 fully paid-up Equity Shares held. The issue is scheduled to open on November 19, 2026, and close on December 3, 2026. The payment structure involves an upfront payment on application and a final call later.